Lung-Focused Celea Secures $180M for Pivotal Test of Pulmonary Fibrosis Drug
PureTech Well being spinout Celea Therapeutics will apply the financing towards a Section 3 check of its idiopathic pulmonary (IPF) ...
PureTech Well being spinout Celea Therapeutics will apply the financing towards a Section 3 check of its idiopathic pulmonary (IPF) ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.